A trial looking at a vaccine to treat children with a type of brain tumour called a high grade glioma
Cancer type:
Status:
Phase:
This trial looked at making personalised 
to see if they could stimulate the immune system to kill brain tumour cells.
More about this trial
This trial was for children between the ages of 3 and 18. We use the term ‘you’ in this summary, but if you are a parent we are referring to your child.
If you have a type of brain tumour called a glioma, and the tumour cells are fast growing (high grade), your treatment may include
- surgery
- radiotherapy
- chemotherapy.
In this trial, doctors wanted to see if adding a vaccine to treatment boosted the immune system to kill more brain tumour cells.
The aims of this trial included
- Seeing how possible it is to make and give these vaccines to children
- Learning more about the safety of the vaccines
- Finding out whether adding this vaccine to
standard treatment helps stimulate the immune system
Summary of results
There were no results in this trial. The trial doctors said that they found the trial was not practical or possible to complete.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr John Anderson
Supported by
Experimental Cancer Medicine Centre (ECMC)
Great Ormond Street Hospital for Children NHS Foundation Trust
Institute of Child Health
Royal Free London NHS Foundation Trust
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
